Total Payments
$6,093
2024 Payments
$1,227
Companies
37
Transactions
336
Medicare Patients
6,359
Medicare Billing
$579,054
Payment Breakdown by Category
Food & Beverage$5,994 (98.4%)
Education$99.00 (1.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,994 | 335 | 98.4% |
| Education | $99.00 | 1 | 1.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,398 | 80 | $0 (2024) |
| Intercept Pharmaceuticals, Inc. | $589.50 | 25 | $0 (2024) |
| Janssen Biotech, Inc. | $552.57 | 27 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $417.34 | 27 | $0 (2022) |
| Takeda Pharmaceuticals U.S.A., Inc. | $366.33 | 24 | $0 (2024) |
| IRONWOOD PHARMACEUTICALS, INC | $353.30 | 21 | $0 (2024) |
| Celgene Corporation | $280.55 | 14 | $0 (2024) |
| Gilead Sciences, Inc. | $240.55 | 12 | $0 (2024) |
| Ardelyx, Inc. | $213.35 | 10 | $0 (2024) |
| Nestle HealthCare Nutrition Inc. | $172.23 | 10 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,227 | 62 | ABBVIE INC. ($383.04) |
| 2023 | $1,355 | 77 | ABBVIE INC. ($443.62) |
| 2022 | $860.96 | 47 | ABBVIE INC. ($281.25) |
| 2021 | $845.05 | 49 | AbbVie Inc. ($268.71) |
| 2020 | $154.92 | 10 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($65.99) |
| 2019 | $702.83 | 37 | Intercept Pharmaceuticals, Inc. ($220.64) |
| 2018 | $696.70 | 39 | Intercept Pharmaceuticals, Inc. ($182.05) |
| 2017 | $250.49 | 15 | Takeda Pharmaceuticals America, Inc. ($54.68) |
All Payment Transactions
336 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $12.62 | General |
| Category: Immunology | ||||||
| 12/12/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $14.80 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | Celltrion USA Inc. | VEGZELMA (Biological) | Food and Beverage | In-kind items and services | $20.03 | General |
| Category: ONCOLOGY | ||||||
| 12/05/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $26.02 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/04/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $22.56 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $15.28 | General |
| 10/22/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $19.60 | General |
| Category: IMMUNOLOGY | ||||||
| 10/14/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $26.04 | General |
| Category: IMMUNOLOGY | ||||||
| 10/10/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $15.92 | General |
| Category: Immunology | ||||||
| 10/09/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/08/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $25.61 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/03/2024 | Celltrion USA Inc. | VEGZELMA (Biological) | Food and Beverage | In-kind items and services | $20.72 | General |
| Category: ONCOLOGY | ||||||
| 10/02/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $19.74 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/01/2024 | EVOKE PHARMA, INC. | GIMOTI (Drug) | Food and Beverage | In-kind items and services | $19.69 | General |
| Category: Gastroenterology | ||||||
| 09/18/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $16.01 | General |
| Category: IMMUNOLOGY | ||||||
| 09/04/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $15.79 | General |
| Category: VIROLOGY | ||||||
| 09/03/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $16.44 | General |
| Category: Immunology | ||||||
| 08/27/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $19.42 | General |
| Category: GI | ||||||
| 08/21/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $17.18 | General |
| 08/20/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $22.03 | General |
| Category: Neuroscience | ||||||
| 08/14/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $24.79 | General |
| Category: Rare Disease | ||||||
| 08/13/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $17.22 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 08/08/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $20.48 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/07/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $31.84 | General |
| Category: IMMUNOLOGY | ||||||
| 08/06/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $20.87 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,485 | 1,574 | $1.1M | $139,599 |
| 2022 | 22 | 1,641 | 1,765 | $1.2M | $156,653 |
| 2021 | 20 | 1,555 | 1,663 | $1.0M | $147,627 |
| 2020 | 23 | 1,678 | 1,797 | $928,275 | $135,174 |
Total Patients
6,359
Total Services
6,799
Medicare Billing
$579,054
Procedure Codes
85
All Medicare Procedures & Services
85 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 192 | 192 | $264,000 | $35,978 | 13.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 198 | 251 | $43,925 | $16,177 | 36.8% |
| 43248 | Insertion of guide wire with dilation of esophagus using a flexible endoscope | Facility | 2023 | 147 | 149 | $130,375 | $13,185 | 10.1% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 154 | 155 | $170,500 | $11,225 | 6.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 127 | 127 | $33,782 | $10,926 | 32.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 124 | 124 | $21,700 | $8,329 | 38.4% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 47 | 47 | $29,845 | $7,854 | 26.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 51 | 75 | $17,700 | $7,592 | 42.9% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 244 | 248 | $190,960 | $6,922 | 3.6% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 48 | 48 | $46,800 | $5,712 | 12.2% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 33 | 33 | $32,175 | $5,643 | 17.5% |
| 45388 | Destruction of polyp or growth of large bowel using a flexible endoscope | Facility | 2023 | 14 | 14 | $21,210 | $2,839 | 13.4% |
| 43251 | Removal of polyps or growths of esophagus, stomach, and/or upper small bowel using an endoscope with mechanical snare | Facility | 2023 | 16 | 20 | $20,500 | $2,100 | 10.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 45 | 45 | $7,650 | $1,850 | 24.2% |
| 91110 | Imaging of digestive tract done from the inside of the digestive tract | Office | 2023 | 17 | 17 | $49,130 | $1,589 | 3.2% |
| 43245 | Dilation of stomach outlet using a flexible endoscope | Facility | 2023 | 13 | 14 | $14,280 | $1,497 | 10.5% |
| 45381 | Injection beneath lining of large bowel using a flexible endoscope | Facility | 2023 | 15 | 15 | $20,175 | $183.33 | 0.9% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 175 | 175 | $240,625 | $31,798 | 13.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 243 | 322 | $56,350 | $20,906 | 37.1% |
| 43248 | Insertion of guide wire with dilation of esophagus using a flexible endoscope | Facility | 2022 | 148 | 152 | $133,000 | $14,063 | 10.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 160 | 160 | $42,560 | $13,963 | 32.8% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 155 | 155 | $170,500 | $11,740 | 6.9% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 58 | 58 | $36,830 | $9,988 | 27.1% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 54 | 54 | $52,650 | $9,300 | 17.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 57 | 84 | $19,824 | $8,667 | 43.7% |
About Dr. Scott Gioe, M.D
Dr. Scott Gioe, M.D is a Specialist healthcare provider based in Gulfport, Mississippi. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1538255815.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Scott Gioe, M.D has received a total of $6,093 in payments from pharmaceutical and medical device companies, with $1,227 received in 2024. These payments were reported across 336 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($5,994).
As a Medicare-enrolled provider, Gioe has provided services to 6,359 Medicare beneficiaries, totaling 6,799 services with total Medicare billing of $579,054. Data is available for 4 years (2020–2023), covering 85 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Location Gulfport, MS
- Active Since 10/05/2006
- Last Updated 07/08/2007
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1538255815
Products in Payments
- OCALIVA (Drug) $573.45
- STELARA (Biological) $408.91
- SKYRIZI (Biological) $353.13
- RINVOQ (Biological) $349.84
- Linzess (Drug) $322.12
- HUMIRA (Biological) $304.78
- ZEPOSIA (Drug) $280.55
- XIFAXAN (Drug) $268.39
- VIBERZI (Drug) $233.40
- IBSRELA (Drug) $213.35
- LINZESS (Drug) $193.61
- ZENPEP (Drug) $172.23
- REMICADE (Biological) $131.04
- Trulance (Drug) $125.62
- GIMOTI (Drug) $122.09
- MAVYRET (Drug) $115.15
- Sucraid (Drug) $103.06
- VOQUEZNA (Drug) $94.39
- Donnatal (Drug) $88.92
- Amitiza (Drug) $84.76
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Gulfport
Dr. Paul Ware, Md, MD
Specialist — Payments: $10,427
Specialist $10,427
Mr. John Douglas, Md, MD
Specialist — Payments: $9,720
Specialist $9,720
Donald Benefield, Md, MD
Specialist — Payments: $6,680
Specialist $6,680
Joseph Cottone, M.d, M.D
Specialist — Payments: $4,260
Specialist $4,260
Vincent Pisciotta, M.d, M.D
Specialist — Payments: $3,705
Specialist $3,705
Michael Seicshnaydre, M.d, M.D
Specialist — Payments: $3,311
Specialist $3,311